Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Heparin
Research in the area of heparin reported from Duke University, Division of Hematology
May 27th, 2009
New investigation results, 'Optimization of a murine immunization model for study of PF4/heparin antibodies,' are detailed in a study published in Journal of Thrombosis and Haemostasis. "Heparin-induced thrombocytopenia (HIT) is a life-threatening thrombotic illness caused by drug-dependent antibodies recognizing complexes of platelet factor 4 (PF4) and heparin. Little is known about the immune pathogenesis of HIT, in particular factors influencing PF4/heparin antibody formation," scientists writing in the Journal of Thrombosis and Haemostasis report. "To gain insight into the biologic basis of heparin sensitization, we have recently developed an animal...
Source: Vaccine Weekly (2009-05-27)
|
